EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Given Consensus Recommendation of “Buy” by Analysts

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) has earned a consensus rating of “Buy” from the eight ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating on the company.

Several research firms recently issued reports on ESLOY. UBS Group raised EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. HSBC upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. The Goldman Sachs Group reissued a “buy” rating on shares of EssilorLuxottica in a report on Friday, December 5th. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. Finally, Citigroup reaffirmed a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th.

EssilorLuxottica Price Performance

Shares of ESLOY stock opened at $141.21 on Tuesday. The firm has a fifty day simple moving average of $154.21 and a 200-day simple moving average of $162.95. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.67 and a current ratio of 0.97. EssilorLuxottica has a twelve month low of $126.47 and a twelve month high of $186.81.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.